News

Apollo Cancer Centres Launch ‘End-O Check’ to Promote Early Detection of Women’s Cancers

The program aims to empower women with awareness, encourage proactive screening, and promote preventive care, particularly among high-risk groups. It highlights the importance of understanding early symptoms and reducing delays in diagnosis through targeted screenings.

• By Newsdesk
• New Delhi
• Aug 08, 2025

News

In a step towards advancing women’s healthcare, Apollo Cancer Centres (ACCs) has launched End-O Check—an early detection program targeting endometrial and ovarian cancers, two of the most prevalent and often underdiagnosed gynaecologic cancers. Designed for women aged 45 and above, the initiative focuses on catching these cancers at an early, more treatable stage.

The program aims to empower women with awareness, encourage proactive screening, and promote preventive care, particularly among high-risk groups. It highlights the importance of understanding early symptoms and reducing delays in diagnosis through targeted screenings.

“Endometrial cancer is increasingly common among women over 45, and early detection significantly improves survival rates,” said Dr. Pakhee Agarwal, Senior Consultant – Gynaecologic Oncology & Robotic Surgery at Apollo Cancer Centre, New Delhi. “If diagnosed at a localized stage, the global five-year survival rate stands at around 96%. However, the prognosis declines sharply when detection is delayed.”

Dr. Agarwal also pointed to key risk factors that are becoming more prevalent in India, including obesity, diabetes, early onset of menstruation, delayed menopause, and polycystic ovary syndrome (PCOS)—all of which increase vulnerability to these cancers.

As part of the End-O Check program, Apollo is integrating advanced radiological tools for early screening. Dr. Reeti, Senior Consultant in Radiology at Apollo Cancer Centre, New Delhi, explained, “Radiology is central to the early identification of gynaecologic cancers. We are leveraging transvaginal ultrasonography (TVS) to detect subtle signs that could indicate early-stage ovarian or endometrial cancer. With early imaging intervention, clinicians can respond faster and improve outcomes.”

The launch of End-O Check reflects Apollo’s commitment to not only treat but also prevent cancer by shifting focus toward early, evidence-based intervention. As rates of gynaecologic cancers rise in India, especially among older women, initiatives like these serve as a critical step in improving survival, awareness, and long-term wellness for women across the country.